Amgen (AMGN) Tops Q2 EPS by 29c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $402.98 -0.01%
EPS Growth %: +2.7%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
VFS, PKE, More
EPS Growth %: +2.7%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $3.83, $0.29 better than the analyst estimate of $3.54. Revenue for the quarter came in at $6.06 billion versus the consensus estimate of $5.73 billion.
GUIDANCE:
Amgen sees FY2018 EPS of $13.30-$14.00, versus the consensus of $13.75. Amgen sees FY2018 revenue of $22.5-23.2 billion, versus the consensus of $22.59 billion.
Sees CapEx at $750 million
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
- Tesla (TSLA) Delivered 486,532 Vehicles in Q3 vs Consensus of 461,974
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
